Research Topics
Species | Elzbieta Senkus-KonefkaSummaryAffiliation: Istituto Clinico Humanitas Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Phase II study of pemetrexed plus carboplatin in malignant pleural mesotheliomaGiovanni L Ceresoli
Department of Medical Oncology and Hematology, Istituto Clinico Humanitas Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan, Italy
J Clin Oncol 24:1443-8. 2006..This multicenter, phase II clinical study was conducted to evaluate the activity of the combination of pemetrexed and carboplatin in patients with malignant pleural mesothelioma (MPM)...
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucoseGiovanni L Ceresoli
Department of Medical Oncology and Hematology, Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy
J Clin Oncol 24:4587-93. 2006..There is growing evidence that therapy-induced changes in tumor [(18)F]fluorodeoxyglucose (FDG) uptake as measured by positron emission tomography (PET) may predict response and patient outcome early in the course of treatment...
Multidisciplinary treatment of malignant pleural mesotheliomaGiovanni Luca Ceresoli
Dipartimento di Oncologia Medica e Ematologia, Istituto Clinico Humanitas IRCCS, Via Manzoni, Rozzano MI, Italy
Oncologist 12:850-63. 2007..However, currently available treatments still appear to have modest results. Further studies are needed to provide evidence-based recommendations for the treatment of early and advanced stages of this disease...
Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiationGiovanni Luca Ceresoli
Department of Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy
Tumori 93:88-96. 2007....
Cardiovascular effects of breast cancer radiotherapyElzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Debinki 7, 80 211 Gdansk, Poland
Cancer Treat Rev 33:578-93. 2007..Additionally, non-cardiac radiation-related vascular morbidity and mortality in breast cancer patients are addressed...
Assessment of tumor response in malignant pleural mesotheliomaGiovanni L Ceresoli
Department of Medical Oncology and Hematology, Istituto Clinico Humanitas IRCCS, Rozzano, Milan, Italy
Cancer Treat Rev 33:533-41. 2007..New serum markers such as osteopontin and mesothelin-related proteins are under evaluation and in the future might play a role in assessing the response of MPM to treatment...
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trialsG L Ceresoli
Department of Oncology, Istituto Clinico Humanitas IRCCS, Rozzano, Milano, Italy
Br J Cancer 99:51-6. 2008..9 months, P=0.12). Apart from slightly worse haematological toxicity, there was no significant difference in outcome or toxicity between age groups. The PC regimen is effective and well tolerated in selected elderly patients with MPM...
The effects of tamoxifen on the female genital tractElzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Debinki 7, Gdansk 80 211, Poland
Cancer Treat Rev 30:291-301. 2004..Further studies are warranted to develop more effective surveillance and methods decreasing the detrimental effects of tamoxifen on the female genital tract...
Intraocular malignant teratoid medulloepithelioma in an adult: clinicopathological case report and review of the literatureKatarzyna Sosinska-Mielcarek
Department of Oncology and Radiotherapy, Medical University of Gedansk, Gedansk, Poland
Acta Ophthalmol Scand 84:259-62. 2006..To report a case of intraocular medulloepithelioma, an embryonal tumour with extremely rare presentation in adults...
Cardiac involvement at presentation of non-small-cell lung cancerKatarzyna Sosinska-Mielcarek
Department of Oncology and Radiotherapy, Medical University of Gdask, Gdask, Poland
J Clin Oncol 26:1010-1. 2008
Radiotherapy for breast cancer in patients undergoing breast reconstruction or augmentationElzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Debinki 7, 80 211 Gdansk, Poland
Cancer Treat Rev 30:671-82. 2004..To minimize the risk of unfavourable outcome, the techniques and timing of both breast reconstruction and radiotherapy should be given meticulous attention...
Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004Elzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland
Breast Cancer Res 6:148-52. 2004..The present article provides a brief description of the most important conference presentations on molecular biology, epidemiology, prevention, pathology, diagnosis and treatment at all stages of breast cancer...
Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancerElzbieta Senkus-Konefka
Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland
Radiother Oncol 79:304-9. 2006..To assess changes in lateral dimensions of irradiated volume during head and neck cancer radiotherapy and to determine their impact on the accuracy of dose delivery...
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern PolandMagdalena Ratajska
Department of Biology and Genetics, Medical University of Gdansk, 80 210 Gdansk, Debinki 1, 80 210, Poland
Oncol Rep 19:263-8. 2008..However, families with strong breast/ovarian cancer history who are negative for these common mutations should be offered a complete BRCA gene screening, including MLPA analysis...
[Late recurrence of malignant tumours 20 years after diagnosis and treatment]Zygmunt Chodorowski
Katedra i Klinika Chorob Wewnetrznych, Geriatrii i Toksykologii Klinicznej, Akademii Medycznej w Gdansku
Przegl Lek 64:372-3. 2007..The histopathological examination results of primary and recurrent tumours were identical. Six patients died at the age from 40 to 89 (mean 66.8) years. The survival of patients after recurrence was from 4 to 11 (mean 7.3) months...
[Efficacy and feasibility evaluation in long term pamidronate treatment of bone metastases]Elzbieta Senkus-Konefka
Katedra i Klinika Onkologii i Radioterapii 80 211 Gdańsk, ul Debinki 7
Przegl Lek 60:467-70. 2003..The aim of our study was to evaluate the efficacy and feasibility of long-term pamidronate treatment...
Exacerbation of diabetes related to exemestane treatmentElzbieta Senkus-Konefka
Acta Oncol 47:1167-9. 2008
